Human leukocyte antigen crossmatch testing is important for liver retransplantation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Liver transplantation

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lt.21981PMID 20209590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.

  2009influential reference
• Unique aspects of rejection and tolerance in liver transplantation.

  2009cited by this paper
• Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility

  2008cited by this paper
• Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes?

  2006cited by this paper
• Influence of HLA compatibility and lymphocyte cross‐matching on acute cellular rejection following living donor adult liver transplantation

  2005cited by this paper
• Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre.

  2005influential reference
• Impact of Surgical and Immunological Parameters in Pediatric Liver Transplantation: A Multivariate Analysis in 500 Consecutive Recipients of Primary Grafts

  2004cited by this paper
• Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores

  2004cited by this paper
• Is presensitization relevant to liver transplantation outcome?

  2002cited by this paper
• Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation

  2001cited by this paper
• A large, single center investigation of the immunogenetic factors affecting liver transplantation.

  2000cited by this paper
• A model to predict survival following liver retransplantation

  1999cited by this paper
• A positive crossmatch in liver transplantation--no effect or inappropriate analysis? A prospective study.

  1997cited by this paper
• Long-term survival after retransplantation of the liver.

  1997cited by this paper
• Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.

  1996cited by this paper
• The impact of a positive crossmatch upon outcome after liver transplantation.

  1996cited by this paper
• Hepatic Retransplantation--an analysis of risk factors associated with outcome.

  1996cited by this paper
• HLA compatibility and liver transplant outcome: improved patient survival by HLA and crossmatching.

  1995cited by this paper
• IgG DONOR‐SPECIFIC CROSSMATCHES ARE NOT ASSOCIATED WITH GRAFT REJECTION OR POOR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: AN ASSESSMENT BY CYTOTOXICITY AND FLOW CYTOMETRY

  1995cited by this paper
• HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.

  1994cited by this paper
• HLA COMPATIBILITY AND LIVER TRANSPLANT OUTCOME Improved Patient Survival by HLA and Cross‐Matching

  1994cited by this paper
• Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.

  1994cited by this paper
• A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies

  1992cited by this paper
• THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2

  1992cited by this paper
• INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE DUCT SYNDROME IN HUMAN LIVER ALLOGRAFTS

  1988cited by this paper
• The antibody crossmatch in liver transplantation.

  1986cited by this paper
• Successful liver transplantation from crossmatch-positive donors.

  1981cited by this paper

• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• Improved outcomes of ABO-incompatible living donor liver transplant with biologically related donors

  2024cites this paper
• B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients

  2021cites this paper
• Liver Retransplantation

  2021cites this paper
• Influence of Preformed Antibodies in Liver Transplantation

  2020cites this paper
• Pregnancy and donor-specific HLA-antibody-mediated rejection after liver transplantation: "Liaisons dangereuses"?

  2019cites this paper
• Recurrent Idiopathic Liver Allograft Failure.

  2019cites this paper
• The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation.

  2019cites this paper
• Limited impact of pre-existing donor specific HLA-antibodies (DSA) on long term allograft survival after first adult liver transplantation.

  2018cites this paper
• [Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation].

  2017cites this paper
• Donor specific HLA Antibodies as a Trigger for Ischemic Type Biliary Lesions (ITBL) after Orthotopic Liver Transplantation-A Case Controlled Study

  2017cites this paper
• Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy.

  2017cites this paper
• University of Birmingham Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients

  2017cites this paper
• Post-liver transplant intrahepatic cholestasis

  2017cites this paper
• Caractérisation de l’allo-immunisation anti-HLA et impact clinique en transfusion et en transplantation d’organe

  2017cites this paper
• Adult to adult right lobe living donor liver transplantation: does biological relationship matter?

  2017cites this paper
• Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group

  2017cites this paper
• Application and interpretation of histocompatibility data in liver transplantation

  2017cites this paper
• Monitoring efficiency of humoral rejection episode therapy in liver transplantation: any role for complement binding Luminex Single Antigen assays?

  2016cites this paper
• The Significance of Screening for HLA Antibodies in the Long-Term Follow-up of Pediatric Liver Transplant Recipients.

  2016cites this paper
• Chapter 89 – ABO, Tissue Typing, and Crossmatch Incompatibility

  2015cites this paper
• The clinical relevance of alloantibody in liver transplantation.

  2015cites this paper
• Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

  2015cites this paper
• Long‐term outcomes and predictors in pediatric liver retransplantation

  2015cites this paper
• Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation

  2015cites this paper
• Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition—Association With Chronic Liver Allograft Failure

  2015cites this paper
• Chapter 102 – Genetic and Genomic Potential in Liver Transplantation

  2015cites this paper
• Biomarkers of Operational Tolerance in Liver Transplantation

  2014cites this paper
• Hepatic retransplant: what have we learned?

  2014cites this paper
• Antibody‐mediated rejection in liver transplantation: Current controversies and future directions

  2014cites this paper
• Clinical Allograft Rejection Syndromes in Liver Transplantation

  2014cites this paper
• Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature.

  2014cites this paper
• Long‐term Outcomes after Liver Transplantation

  2014cites this paper
• Monitoring for HLA Antibody after Organ Transplantation

  2014cites this paper
• Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume

  2014cites this paper
• Excellent liver retransplantation outcomes in hepatitis C‐infected recipients

  2013cites this paper
• Preformed class II donor‐specific antibodies are associated with an increased risk of early rejection after liver transplantation

  2013cites this paper
• De NovoDonor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients: De NovoDSA in Liver Transplantation

  2013cites this paper
• Impact of donor-specific antibodies on results of liver transplantation

  2013cites this paper
• Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

  2013cites this paper
• Significance of True-Positive and False-Positive Pretransplantation Lymphocytotoxic Crossmatch in Primary Liver Allograft Outcomes

  2013cites this paper
• Predicting Operational Tolerance in Pediatric Living-Donor Liver Transplantation by Absence of HLA Antibodies

  2013cites this paper
• De Novo Donor‐Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients

  2013cites this paper
• Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.

  2012cites this paper
• Progressive graft fibrosis and donor‐specific human leukocyte antigen antibodies in pediatric late liver allografts

  2012cites this paper
• Liver allograft antibody‐mediated rejection with demonstration of sinusoidal C4d staining and circulating donor‐specific antibodies

  2011cites this paper
• High Mean Fluorescence Intensity Donor‐Specific Anti‐HLA Antibodies Associated With Chronic Rejection Postliver Transplant

  2011cites this paper
• The Significance of Donor‐Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation

  2011cites this paper
• Human leukocyte antigen antibodies in liver retransplantation

  2010cites this paper